Interpace Biosciences, Inc. (IDXG)
1.43
-0.09
(-6.09%)
USD |
OTCM |
Aug 24, 16:00
Interpace Biosciences Debt to Equity Ratio : 0.0419 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0419 |
| March 31, 2026 | 0.0468 |
| December 31, 2025 | 0.0529 |
| September 30, 2025 | -7.584 |
| June 30, 2025 | -2.598 |
| March 31, 2025 | -7.284 |
| December 31, 2024 | -2.641 |
| September 30, 2024 | -0.6444 |
| June 30, 2024 | -0.6717 |
| March 31, 2024 | -0.7241 |
| December 31, 2023 | -1.243 |
| September 30, 2023 | -0.8384 |
| June 30, 2023 | -0.9506 |
| March 31, 2023 | -0.9763 |
| December 31, 2022 | -0.9731 |
| September 30, 2022 | -0.886 |
| June 30, 2022 | -11.32 |
| March 31, 2022 | 6.529 |
| December 31, 2021 | 2.604 |
| September 30, 2021 | 1.550 |
| June 30, 2021 | 1.111 |
| March 31, 2021 | 0.7019 |
| December 31, 2020 | 0.2797 |
| September 30, 2020 | 0.203 |
| June 30, 2020 | 0.2867 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1145 |
| December 31, 2019 | 0.3328 |
| September 30, 2019 | 0.4122 |
| June 30, 2019 | 0.075 |
| March 31, 2019 | 0.0678 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.1776 |
| December 31, 2016 | 1.211 |
| September 30, 2016 | -6.101 |
| June 30, 2016 | 1.47 |
| March 31, 2016 | 1.035 |
| September 30, 2015 | 4.762 |
| June 30, 2015 | 2.689 |
| March 31, 2015 | 1.645 |
| December 31, 2014 | 1.350 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Exlites Holdings International, Inc. | 0.00 |
| Xcelerate, Inc. | -0.8535 |
| Vivos Therapeutics, Inc. | -3.278 |
| Hinge Health, Inc. | 0.0171 |
| PD-Rx Pharmaceuticals, Inc. | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 34.55M |
| Total Liabilities (Quarterly) | 11.30M |
| Shareholders Equity (Quarterly) | 23.24M |
| Current Ratio | 2.215 |
| Net Debt Paydown Yield | 1.45% |